home.aspx
 
. https://biotechnology.report/Resources/Whitepapers/432c9592-980d-4d7c-b1f5-d8e6ebec6f36_Patient-Centered-Care-in-Type-2.pdf
whitepaper
SHARESHARESHARE
PATIENT-CENTERED CARE IN TYPE 2 DIABETES MELLITUS
There have been many advancements in pharmacologic agents for the treatment of type 2 diabetes mellitus (T2DM) during the past 3 decades. At the same time, evidence in support of interventional approaches, the relationship between clinical parameters and chronic complications, and effective self-management behaviors has grown exponentially and has informed providers and patients of effective strategies for controlling blood glucose and other risk factors to minimize the risk of complications. DOWNLOAD